Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sara Lorente
Neutrophil-To-Lymphocyte Ratio Predicts Survival in European Patients With Hepatocellular Carcinoma Administered Sorafenib
Oncotarget
Oncology
Related publications
High Preoperative Neutrophil-Lymphocyte Ratio Predicts Poor Survival in Patients With Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Journal of Hepatocellular Carcinoma
Pre-Treatment Neutrophil to Lymphocyte Ratio Predicts the Chemoradiotherapy Outcome and Survival in Patients With Oral Squamous Cell Carcinoma: A Retrospective Study
BMC Cancer
Cancer Research
Oncology
Genetics
Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients With Advanced Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients With NSCLC
Materia Socio Medica
Prognostic Role of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio in Patients With Bone Metastases
British Journal of Cancer
Cancer Research
Oncology
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
Hepatology Research
Hepatology
Infectious Diseases
Stratified Aspartate Aminotransferase-To-Platelet Ratio Index Accurately Predicts Survival in Hepatocellular Carcinoma Patients Undergoing Curative Liver Resection
Tumor Biology
Medicine
Cancer Research
